COL17A1 and stroke disorder: Sera from 11 (11.0%) patients with stroke and 2(2.0 %) healthy controls recognized both of the human recombinant full length BP180 (P = 0.018) (Figure 1B) and human recombinant NC16A (P = 0.018) (Figure 1C).